Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs UDR✓SelectedUSD · UDRGSK vs UDR performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs UDR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
UDR return
+23.2%
Excess return
+29.5%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioUDRExcessAlpha
1D-0.1%+0.3%-0.5%-0.2%
7D-5.3%-2.3%-3.0%-4.6%
30D-3.7%+1.6%-5.2%-4.0%
3M-7.3%-4.8%-2.5%-5.9%
6M-4.2%-4.4%+0.2%-2.9%
YTD+0.9%+1.0%-0.1%+0.4%
1Y+7.3%+6.8%+0.5%+5.2%
3Y+52.7%+21.4%+31.3%+47.7%
All+52.7%+23.2%+29.5%+47.7%

Cumulative growth

Daily Returns

Daily percentage return beside UDR.

Daily Out/Under-Performance

Portfolio return minus UDR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × UDR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded UDR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling